Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-National Phase III Study of Satraplatin Plus Prednisone or Placebo Plus Prednisone in Patients With Hormone Refractory Prostate Cancer Previously Treated With One Cytotoxic Chemotherapy Regimen

NCT00069745 is registered in ClinicalTrials.gov with Agennix as lead sponsor.

NCT NCT00069745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-National Phase III Study of Satraplatin Plus Prednisone or Placebo Plus Prednisone in Patients With Hormone Refractory Prostate Cancer Previously Treated With One Cytotoxic Chemotherapy Regimen
Lead sponsor
Agennix
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
March 31, 2007
Enrollment
Not reported
Sites
211

Conditions

As the registry lists them; a condition with its own page is linked.

hormone refractory prostate cancer, prostate cancer